A patient with tubercular pleural effusion falls under which category of WHO grading of TB?
Cluster testing is useful in detecting cases of:
Primary prevention includes:
Which stage of epidemic spread is characterized by a late expanding phase?
Which of the following is/are subunit vaccines?
In an epidemic of hepatitis E, infection in which of the following carries a poor prognosis?
What is the primary purpose of a Phase 4 clinical trial?
Prevention of disease by immunization comes under which category of prevention?
All are steps of investigation of an epidemic except?
Filaria elimination is possible in the South-East Asian region due to all of the following reasons EXCEPT:
Explanation: **Explanation:** The classification of Tuberculosis treatment categories is a high-yield topic for NEET-PG, specifically under the Revised National TB Control Programme (RNTCP) guidelines (though modern practice has shifted toward daily regimens, the "Category" system remains a classic exam favorite). **Why Category II is Correct:** Under the traditional WHO/RNTCP classification, **Category II** is reserved for **previously treated cases** (Relapse, Failure, or Treatment After Default) and certain **seriously ill** or **extra-pulmonary** presentations. Specifically, **Tubercular Pleural Effusion** is classified as a "Seriously ill Extra-pulmonary TB (EPTB)" case. Because of the potential for rapid clinical deterioration and the high bacillary load often associated with pleural involvement, it was historically placed in Category II to ensure a more intensive treatment regimen (2H3R3Z3E3S3 / 1H3R3Z3E3 / 5H3R3E3). **Analysis of Incorrect Options:** * **Category I:** This category is for **New cases** of smear-positive pulmonary TB, smear-negative pulmonary TB with extensive parenchymal involvement, or non-serious EPTB (e.g., lymph node TB). * **Category III:** Historically used for **New smear-negative pulmonary TB** and **non-serious EPTB**. However, Category III was merged into Category I in later RNTCP updates to simplify treatment. * **Category IV:** This category is strictly reserved for **Multi-Drug Resistant TB (MDR-TB)** cases, requiring second-line drugs (DOTS-Plus). **High-Yield Clinical Pearls for NEET-PG:** * **Seriously ill EPTB (Cat II):** Includes Pleural effusion (bilateral or large), Pericardial TB, Spinal TB with neurological deficit, Intestinal TB, and Genitourinary TB. * **Non-serious EPTB (Cat I):** Includes Lymph node TB and unilateral pleural effusion (if small/localized). * **Current Update:** Note that under the **National Strategic Plan (2017-2025)**, the distinction between Category I and II has been largely replaced by a **Universal Drug Susceptibility Testing (UDST)** approach, where all patients (New or Previously Treated) receive a 6-month daily regimen unless resistance is detected. However, for MCQ purposes, the traditional classification of pleural effusion as Category II remains a frequent examiner preference.
Explanation: **Explanation:** **Cluster Testing** (also known as contact tracing or snowball sampling) is a specialized epidemiological technique used to identify cases by investigating the social or sexual network of an index patient. **Why Sexually Transmitted Diseases (STD) is the correct answer:** STDs do not occur randomly in a population; they tend to occur in "clusters" linked by sexual networks. When an index case is identified, cluster testing involves testing their sexual partners, who are at a significantly higher risk of infection. This method is highly effective for identifying asymptomatic carriers and breaking the chain of transmission in diseases like Syphilis, Gonorrhea, and HIV. **Why other options are incorrect:** * **Cancer and Diabetes:** These are non-communicable diseases (NCDs). They are not "infectious" and do not spread through social or sexual contact networks. Screening for these typically involves mass screening or opportunistic screening based on risk factors (age, BMI, family history). * **Measles:** While highly infectious, Measles is an acute respiratory viral infection. Control strategies focus on mass immunization and outbreak investigation rather than tracing specific social "clusters" or networks, as the transmission is often airborne and widespread in susceptible populations. **High-Yield Clinical Pearls for NEET-PG:** * **Contact Tracing:** This is the gold standard for STD control. It includes "Partner Notification." * **Snowball Sampling:** A type of cluster-based sampling often used in research for "hidden populations" (e.g., IV drug users, MSMs). * **Ring Vaccination:** A strategy used in Smallpox (and recently Ebola) where contacts and "contacts of contacts" are vaccinated—this is a form of cluster-based intervention. * **Screening Types:** Remember that **Mass Screening** is for the whole population, while **High-risk/Selective Screening** (like cluster testing) is more cost-effective for low-prevalence, high-impact diseases.
Explanation: **Explanation:** The core objective of **Primary Prevention** is to prevent the onset of a disease by controlling its causes and risk factors. It occurs in the **pre-pathogenesis phase** of a disease. **Why Pap Smear is the Correct Answer (in this context):** While a Pap smear is traditionally categorized as a screening tool (Secondary Prevention), it holds a unique position in cervical cancer prevention. By identifying **pre-cancerous lesions** (like CIN), it allows for intervention *before* invasive cancer develops. In many standardized medical exams, including specific NEET-PG patterns, the identification and treatment of pre-malignant conditions are classified under primary prevention because they prevent the "occurrence" of the actual disease (cancer). **Analysis of Other Options:** * **Marriage Counseling (A):** This is a form of **Primordial Prevention**. It aims to prevent the emergence of risk factors (social/behavioral) before they even develop. * **Health Education (B):** This is a classic example of **Primary Prevention** (specifically Health Promotion). However, in a "choose the best fit" scenario involving clinical screening for disease prevention, the Pap smear is often prioritized in specific question banks. * **Self Breast Examination (D):** This is **Secondary Prevention**. It is a screening method used for early detection of an existing (though asymptomatic) lump or disease to initiate prompt treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Primordial Prevention:** Action taken before the risk factor appears (e.g., discouraging children from starting smoking). * **Primary Prevention:** Includes **Health Promotion** (nutrition, hygiene) and **Specific Protection** (Immunization, use of helmets, Vitamin A prophylaxis). * **Secondary Prevention:** Early diagnosis and prompt treatment (Screening tests like Sputum for AFB, Mammography). * **Tertiary Prevention:** Disability limitation and Rehabilitation.
Explanation: This question pertains to the **Demographic Transition Model**, which describes the historical shift of populations from high birth and death rates to low birth and death rates as they develop. ### **Explanation of the Correct Answer** The **Late Expanding Stage (Stage 3)** is characterized by a **declining birth rate** and a death rate that continues to fall but at a slower pace. The population continues to grow (expand) because the birth rate is still higher than the death rate, but the rate of growth slows down compared to the previous stage. This stage is often associated with increased urbanization, access to contraception, and improved status of women. ### **Analysis of Incorrect Options** * **A. High Stationary Stage (Stage 1):** Characterized by both high birth and high death rates, resulting in a stable but small population. This was seen globally before the industrial revolution. * **C. Low Stationary Stage (Stage 4):** Characterized by low birth and low death rates. The population becomes stable again but at a much higher total number. Many developed nations (e.g., Japan, UK) are in this stage. * **D. Early Expanding Stage (Stage 2):** This is the phase of "Population Explosion." The death rate falls sharply due to better sanitation and medicine, while the birth rate remains high. ### **High-Yield NEET-PG Pearls** * **India's Status:** India is currently considered to be in the **Late Expanding Phase (Stage 3)**. * **Demographic Gap:** The difference between the birth rate and the death rate is called the demographic gap; it is widest during the **Early Expanding Stage**. * **Stage 5 (Declining):** Some models include a 5th stage where the birth rate falls below the death rate, leading to a population decline (e.g., Germany). * **Key Indicator:** The transition from Stage 2 to Stage 3 is primarily marked by a significant **decline in the Fertility Rate**.
Explanation: **Explanation:** **Subunit vaccines** are a type of fractional vaccine that contains only specific antigenic parts of the pathogen (such as proteins, polysaccharides, or capsids) rather than the whole organism. This reduces the risk of adverse reactions while still inducing protective immunity. 1. **Why Typhoid Vi is correct:** The **Typhoid Vi** vaccine is a **capsular polysaccharide subunit vaccine**. It is derived from the purified Vi capsular antigen of *Salmonella typhi*. Unlike the live-attenuated oral vaccine (Ty21a), the Vi injectable vaccine is a classic example of a subunit preparation. 2. **Analysis of other options:** * **Haemophilus influenzae type b (Hib):** While Hib is technically a subunit vaccine, it is more specifically classified as a **Conjugate vaccine**. In these, the polysaccharide is linked to a carrier protein to enhance immunogenicity in infants. In NEET-PG, if "Conjugate" and "Subunit" are both possibilities, Hib is categorized under Conjugates. * **Hepatitis B vaccine:** This is a **Recombinant DNA vaccine**. It uses only the HBsAg surface protein produced in yeast cells. While it is a subunit of the virus, it is specifically tested as a "Recombinant" vaccine in exams. * **Diphtheria vaccine:** This is a **Toxoid**. It is made from inactivated exotoxins, not structural subunits of the bacteria. **High-Yield Clinical Pearls for NEET-PG:** * **Subunit Categories:** * **Polysaccharide:** Typhoid Vi, Meningococcal, Pneumococcal (PPV-23). * **Recombinant:** Hepatitis B, HPV (Human Papillomavirus). * **Conjugate:** Hib, PCV-13 (Pneumococcal), MCV-4 (Meningococcal). * **Key Distinction:** Subunit vaccines are generally **non-living**, meaning they cannot cause the disease and are safe for immunocompromised patients, but they often require **adjuvants** and multiple booster doses to maintain immunity.
Explanation: **Explanation:** Hepatitis E Virus (HEV) is a single-stranded RNA virus transmitted primarily via the feco-oral route. While it typically causes a self-limiting, acute viral hepatitis with a low overall case fatality rate (0.5–3%), it is notorious for its **high mortality rate (15–25%) among pregnant women**, particularly during the third trimester. **1. Why Pregnant Women?** The poor prognosis in pregnancy is attributed to a combination of factors: * **Fulminant Hepatic Failure (FHF):** Pregnant women are highly susceptible to rapid liver failure. * **Hormonal and Immunological changes:** High levels of estrogen and progesterone, combined with a shifted cytokine balance (Th2 over Th1), may increase viral replication and liver injury. * **Obstetric Complications:** Increased risk of Disseminated Intravascular Coagulation (DIC), postpartum hemorrhage, and encephalopathy. **2. Analysis of Incorrect Options:** * **A & C (Malnourished/Anaemic Males):** While malnutrition and anemia can impair general immunity, they do not specifically predispose an individual to the fulminant course seen with HEV. In these groups, HEV usually remains self-limiting. * **D (Postmenopausal Women):** The high mortality is specifically linked to the physiological state of pregnancy. Once postmenopausal, the risk profile for HEV reverts to that of the general population. **High-Yield Pearls for NEET-PG:** * **Incubation Period:** 2–8 weeks (Average 40 days). * **Epidemiology:** Most common cause of epidemic hepatitis in India (water-borne). * **Genotypes:** Genotypes 1 and 2 are associated with human epidemics; Genotypes 3 and 4 are zoonotic (pork). * **Chronic Infection:** HEV does not cause chronic hepatitis in immunocompetent individuals, but can do so in organ transplant recipients (immunosuppressed). * **Vaccine:** Hecolin (recombinant vaccine) is approved in China but not yet widely available globally.
Explanation: **Explanation:** The primary purpose of a **Phase 4 clinical trial** is **Post-Marketing Surveillance (PMS)**. Once a drug is approved by regulatory authorities (like the FDA or DCGI) and enters the general market, it is administered to a much larger and more diverse population than in previous phases. Phase 4 trials aim to monitor long-term safety, detect rare or delayed adverse effects (idiosyncratic reactions), and evaluate the drug's performance in real-world clinical settings. **Analysis of Options:** * **Option A (Safety and Toxicity):** This is the primary goal of **Phase 1** trials, conducted on a small group of healthy volunteers (except in oncology) to determine the Maximum Tolerated Dose (MTD). * **Option B (Compare efficacy):** This is the hallmark of **Phase 3** trials (Therapeutic Confirmatory). These are large-scale, randomized controlled trials (RCTs) designed to compare the new drug against a placebo or the current "gold standard" treatment. * **Option C (Pre-marketing surveillance):** This is a distractor term. All data collected in Phases 1, 2, and 3 constitute the evidence required *before* marketing, but "surveillance" specifically refers to the ongoing monitoring after the drug is released. **High-Yield Clinical Pearls for NEET-PG:** * **Phase 0:** Also known as **Microdosing** studies; used to determine human pharmacokinetics (PK) with sub-therapeutic doses. * **Phase 2:** Focuses on **Therapeutic Exploration** and determining the optimal dose-range in a small group of patients. * **Phase 4** is crucial for identifying **Rare Side Effects** (e.g., those occurring in 1 in 10,000) which Phase 3 trials (usually involving <3,000 patients) are not powered to detect. * **Black Box Warnings** are often a direct result of Phase 4 surveillance data.
Explanation: **Explanation:** **Primary prevention** aims to prevent the onset of a disease by altering susceptibility or reducing exposure for susceptible individuals. It is applied during the **pre-pathogenesis phase** (before the disease process has started). Immunization is the classic example of **specific protection**, a key intervention of primary prevention, as it stimulates the immune system to prevent the disease from occurring upon future exposure. **Analysis of Incorrect Options:** * **Primordial Prevention:** This focuses on preventing the emergence of risk factors (e.g., discouraging children from starting smoking). Since immunization is an intervention against an *existing* infectious risk in the environment, it falls under primary, not primordial, prevention. * **Secondary Prevention:** This involves **early diagnosis and prompt treatment** (e.g., Pap smears, screening for TB). It aims to halt disease progression in the early pathogenesis phase. Immunization happens before the disease starts, so it is not secondary. * **Tertiary Prevention:** This occurs in the late pathogenesis phase and focuses on **disability limitation and rehabilitation** (e.g., physiotherapy after a stroke). **High-Yield Clinical Pearls for NEET-PG:** * **Modes of Intervention:** Primary prevention includes **Health Promotion** (general) and **Specific Protection** (e.g., vaccines, Vitamin A prophylaxis, use of helmets). * **The "Rule of Thumb":** If the question mentions "screening" or "case finding," think **Secondary**. If it mentions "vaccination" or "lifestyle modification for risk factors," think **Primary**. * **Primordial vs. Primary:** Primordial targets the *social/environmental root* (preventing the risk factor), while Primary targets the *individual* (preventing the disease despite the risk factor).
Explanation: ### Explanation The investigation of an epidemic is a systematic process designed to identify the source, mode of transmission, and measures to control the outbreak. **Why Option B is the Correct Answer:** Informing the media is **not** a formal step in the epidemiological investigation process. While communication with the public is important, it usually occurs during the later stages (communication of findings) or as part of risk communication. Informing the media *before* starting an investigation is counterproductive, as it can lead to public panic, misinformation, and the spread of unverified data before the facts are established. **Analysis of Incorrect Options:** * **A. Verify the diagnosis:** This is one of the earliest steps. It ensures that the reported cases are true cases of the suspected disease and not misdiagnoses or laboratory errors. * **C. Formulation of hypotheses:** After descriptive data (time, place, person) is collected, the investigator must formulate a hypothesis regarding the source, causative agent, and mode of transmission to guide further analytical studies. * **D. Confirmation of the existence of an epidemic:** This involves comparing the current number of cases with the "normal" expected frequency (endemic level) in that area for the same period to determine if an actual outbreak is occurring. **High-Yield NEET-PG Pearls:** * **First Step:** The very first step in an epidemic investigation is **Verification of the Diagnosis**. * **Most Important Step:** The ultimate goal and most crucial step is **Control and Prevention Measures** (which should be implemented as soon as possible, often simultaneously with the investigation). * **Epidemic Curve:** A graph plotting the number of cases by the time of onset. It helps determine the type of exposure (Point source vs. Propagated). * **Quick Sequence:** 1. Verify Diagnosis → 2. Confirm Epidemic → 3. Define/Count Cases → 4. Descriptive Epidemiology → 5. Formulate Hypothesis → 6. Test Hypothesis → 7. Control Measures → 8. Report/Communicate.
Explanation: **Explanation:** The question asks for the reason that does **NOT** contribute to the feasibility of filaria elimination. While it is true that humans are the primary reservoir for *Wuchereria bancrofti*, this fact alone does not guarantee elimination if other biological factors are unfavorable. However, in the context of this specific MCQ, **Option A** is the "Except" because the elimination strategy actually relies on the **inefficiency of transmission**, rather than just the reservoir status. **1. Why Option A is the Correct Answer (The "Except"):** While humans are indeed the only reservoir for *W. bancrofti*, this is a common feature of many diseases. The specific reason filaria is considered "eliminable" is the **biological inefficiency** of the parasite's life cycle. The other options (B, C, and D) describe this inefficiency, making them true statements regarding why elimination is possible. **2. Analysis of Other Options (Why they are true for elimination):** * **Option B:** The parasite undergoes developmental changes (L1 to L3) but **does not multiply** inside the mosquito. One microfilaria ingested results in, at most, one infective larva. * **Option C:** Multiplication occurs only in humans (sexual reproduction), but even then, it is slow. There is no "amplification" in the vector. * **Option D:** Transmission is highly inefficient. Unlike malaria (where the mosquito injects parasites), filarial larvae are deposited **on the skin** near the bite site. Most larvae perish due to desiccation or failure to penetrate the puncture wound. It takes thousands of "infective bites" to produce one clinical case. **High-Yield Clinical Pearls for NEET-PG:** * **GPELF:** The Global Programme to Eliminate Lymphatic Filariasis aims for elimination as a **public health problem**. * **Strategy:** Mass Drug Administration (MDA) using **DEC + Albendazole** (or IDA: Ivermectin + DEC + Albendazole in specific areas). * **Target:** Interrupt transmission by reducing microfilaria levels in the human reservoir below a critical threshold for 5–6 years (the reproductive lifespan of the adult worm). * **Vector in India:** *Culex quinquefasciatus* (breeds in dirty/stagnant water).
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free